-+ 0.00%
-+ 0.00%
-+ 0.00%

Lucid Diagnostics prices $18 million stock offering at $1 per share

PUBT·04/23/2026 12:33:50
Listen to the news
Lucid Diagnostics prices $18 million stock offering at $1 per share
  • Lucid Diagnostics priced an underwritten registered direct offering of 18,000,000 common shares at USD 1 per share.
  • Gross proceeds expected at about USD 18 million before fees.
  • Net proceeds earmarked for working capital and general corporate purposes.
  • Closing expected on or about April 24, 2026, subject to customary conditions.
  • Canaccord Genuity, BTIG serving as joint bookrunners.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lucid Diagnostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY41751) on April 23, 2026, and is solely responsible for the information contained therein.